2005
DOI: 10.1186/1475-925x-4-39
|View full text |Cite
|
Sign up to set email alerts
|

A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia

Abstract: BackgroundProstate cancer and benign prostatic hyperplasia are very common diseases in older American men, thus having a reliable treatment modality for both diseases is of great importance. The currently used treating options, mainly surgical ones, have numerous complications, which include the many side effects that accompany such procedures, besides the invasive nature of such techniques. Focused ultrasound is a relatively new treating modality that is showing promising results in treating prostate cancer a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…The two dominant clinically available systems using transrectal HIFU are Ablatherm HIFU (Technomed International, Lyon, France) and HIFU Sonablate 500 (Focal Surgery, Milpitas, CA now SonaCare Medical, Charlotte, North Carolina). Recent advances of the transrectal device include a phased array probe for more efficient treatment of prostate [ 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…The two dominant clinically available systems using transrectal HIFU are Ablatherm HIFU (Technomed International, Lyon, France) and HIFU Sonablate 500 (Focal Surgery, Milpitas, CA now SonaCare Medical, Charlotte, North Carolina). Recent advances of the transrectal device include a phased array probe for more efficient treatment of prostate [ 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…Linear 1D arrays can steer the beam in the axial plane of the array, and have also been proposed for endocavity applications (Buchanan and Hynynen 1994, Diederich and Burdette 1996, Gavrilov and Hand 1997. For completeness, it is worth noting that 1.25D, 1.5D, and 1.75D arrays (for definitions, see Wildes et al (1997)) have also been proposed for use in therapy arrays (Wildes et al 1997, Curiel et al 2002, Saleh and Smith 2005.…”
Section: D Arraysmentioning
confidence: 99%
“…The two dominant clinically available systems using transrectal HIFU are Ablatherm HIFU (Technomed International, Lyon, France) and HIFU Sonablate 500 (Focal Surgery, Milpitas, CA now SonaCare Medical, Charlotte, NC, USA). Recent advances of the transrectal device includes a phased-array probe for more efficient treatment of the prostate [ 23 ]. Another clinical success that employs therapeutic ultrasound with magnetic imaging guidance (MRI) is the technology introduced by the Israeli company InSightec [ 24 ].…”
Section: Introductionmentioning
confidence: 99%